Trial Profile
A phase I randomized, double-blind, placebo-controlled study in healthy male volunteers to examine the safety, tolerability, and pharmacokinetics of HMPL-011 after multiple dosing for 14 days.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 21 Mar 2022
Price :
$35
*
At a glance
- Drugs HMPL 011 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Hutchison MediPharma; HUTCHMED
- 18 Jul 2011 New trial record